argus

Cohance Lifesciences Limited

NSE: COHANCEINE03QK0101817,559 Cr

Timeline

Time (IST)TypeMEventSrc
26 Aug, 08:12 pmCohance Lifesciences Ltd - 543064 - Reg. 34 (1) Annual Report.bse
26 Aug, 07:59 pmCohance Lifesciences Limited has informed the Exchange about submission of BRSRnse
26 Aug, 07:56 pmCohance Lifesciences Limited has informed the Exchange about Integrated Annual Report 2026nse
13 Aug, 12:35 pmCohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
13 Aug, 12:30 pmCohance Lifesciences Limited has informed the Exchange about Credit Rating- Othersnse
12 Aug, 11:10 amCohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
11 Aug, 05:13 pmCohance Lifesciences Limited has informed the Exchange about Transcriptnse
11 Aug, 05:09 pmCohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
05 Aug, 09:49 pmCohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
05 Aug, 09:43 pmCohance Lifesciences Limited has informed the Exchange about Link of Recordingnse
05 Aug, 06:43 pmCohance Lifesciences Limited has informed the Exchange about Completion of USFDA Inspectionnse
05 Aug, 06:08 pmCohance Lifesciences Limited has informed the Exchange about Investor Presentationnse
05 Aug, 06:06 pmCohance Lifesciences Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Press Release".nse
05 Aug, 06:01 pmCohance Lifesciences Ltd - 543064 - Outcome Of The Board Meetingbse
05 Aug, 05:54 pmCohance Lifesciences Ltd - 543064 - Board Meeting Outcome for Outcome Of The Board Meetingbse
05 Aug, 05:48 pmCohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
23 Jul, 09:27 pmCohance Lifesciences Limited has informed the Exchange about allotment of Equity Shares pursuant to exercise of Stock Options and grant of Stock Options to certain eligible employees of the Companynse
23 Jul, 12:15 pmCohance Lifesciences Ltd - 543064 - Board Meeting Intimation for Considering The Unaudited Financial Results (Standalone And Consolidated) Of The Company, For The Quarter Ended 30 June 2026bse
20 Jul, 06:29 pmThe Exchange had sought clarification from Cohance Lifesciences Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.nse
30 Jun, 03:58 pmJusmiral Holdings Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
24 Jun, 04:07 pmCohance Lifesciences Ltd - 543064 - Clarification On Volume Movementbse
24 Jun, 02:32 pmCohance Lifesciences Ltd - 543064 - Clarification sought from Cohance Lifesciences Ltdbse
23 Jun, 08:45 pmBerhyanda Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
19 Jun, 12:32 pmCohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011bse
19 Jun, 11:31 amCohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
19 Jun, 11:30 amCohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011bse
18 Jun, 06:19 pmCohance Lifesciences Limited has informed the Exchange about Resignation of Director/KMP/SMPnse
18 Jun, 03:42 pmCohance Lifesciences Ltd - 543064 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.bse
18 Jun, 03:31 pmCohance Lifesciences Ltd - 543064 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011bse
18 Jun, 03:29 pmCohance Lifesciences Ltd - 543064 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011bse
17 Jun, 10:33 pmCohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Resignation of Directorbse
17 Jun, 10:31 pmCohance Lifesciences Limited has informed the Exchange regarding Resignation of Himanshu Agarwal as Executive Director and Chief Financial Officer of the company w.e.f. September 13, 2026.nse
30 May, 04:01 pmCohance Lifesciences Ltd - 543064 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
15 May, 08:54 pmCohance Lifesciences Limited has informed the Exchange about Transcriptnse
15 May, 08:53 pmCohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
12 May, 09:21 pmCohance Lifesciences Limited has informed the Exchange about Link of Recordingnse
12 May, 09:18 pmCohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
12 May, 06:02 pmCohance Lifesciences Limited has informed the Exchange about Investor Presentationnse
12 May, 05:43 pmCohance Lifesciences Ltd - 543064 - Outcome Of The Board Meetingbse
12 May, 05:39 pmCohance Lifesciences Ltd - 543064 - Board Meeting Outcome for Outcome Of The Board Meetingbse
12 May, 05:37 pmCohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
06 May, 03:05 pmCohance Lifesciences Ltd - 543064 - Board Meeting Intimation for To Consider And Approve The Audited Financial Results (Standalone And Consolidated) Of The Company, For The Quarter And Financial Year Ended March 31, 2026.bse
30 Apr, 10:59 amCohance Lifesciences Ltd - 543064 - Clarification On Movement In Price Of Equity Sharesbse
30 Apr, 10:57 amSignificant movement in price has been observed in Cohance Lifesciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Cohance Lifesciences Limited has submitted their response.nse
29 Apr, 07:43 pmSignificant movement in price has been observed in Cohance Lifesciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse
29 Apr, 06:48 pmCohance Lifesciences Ltd - 543064 - Clarification sought from Cohance Lifesciences Ltdbse
27 Apr, 08:03 pmCohance Lifesciences Limited has informed the Exchange about Resignation of Director/KMP/SMPnse
27 Apr, 02:40 pmCohance Lifesciences Limited has informed the Exchange about Brief profile of Mr. Umang Vohra, Chairman and Group CEOnse
27 Apr, 09:06 amCohance Lifesciences Limited has informed the Exchange regarding a press release dated April 27, 2026, titled "Press Release".nse
27 Apr, 09:06 amCohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse